ReviewReviews in endocrine & metabolic disorders2025
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.
Review in Reviews in endocrine & metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Gut Microbiota-Metabolite-Host Axis in Cardiometabolic Diseases: Bridging Bench to Bedside.Cardiovascular drugs and therapy · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cardiovascular diseases (CVD) are major lethal diseases worldwide. Imbalance of gut microbiota (GM) homeostasis affects the development and progression of CVD. Exercise can remodel GM and improve GM disorders in CVD patients. By combing the research progress of GM-mediated exercise intervention for CVD, it was found that 1) Streptococcus, Lactococcus, Enterobacter, Klebsiella, and Turicibacter are pathogenic bacteria in CVD patients; 2) Response to exercise to modulate the microbiota of CVD includes increasing the abundance of beneficial bacteria such as Bifidobacteria, Lactobacillus, Bacteroides, Faecalobacteria, and Roseburia, decreasing the proportion of Streptococcus, Enterobacter, and other pathogenic bacteria, and regulating metabolite-producing bacteria such as Prevotella and Ruminococcus; 3) Exercise can improve the CVD process via GM, by remodeling physiological mechanisms such as vascular function, cardiac function, autonomic function and hemodynamics, and molecular mechanisms such as regulation of DNA methylation, histone modification, non-coding RNAs; 4) Most of the existing studies have focused on aerobic exercise. The specific mechanisms, individualized intervention programs and long-term effects of different types of exercise on GM in CVD patients need to be further explored.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.